Control Medical Technology, LLC announced the closing of a Series A financing with a team of medical device manufacturers, global distributors, and investors. Spring Bay Ventures, a medical-technology focused investor based in Jacksonville, Florida, led the funding. Control Medical’s ASPIRE aspiration platform under development may be used to remove fluids, tissue, thrombus (blood clots), and other pathology for use in cardiovascular, oncology, spine, pain management, wound irrigation/lavage, and general procedures. Control Medical is also planning to expand the ASPIRE platform into thrombus aspiration for heart attack, stroke, and hemodialysis access.